Recombinant Bombali ebolavirus in cynomolgus macaques as a survival model of Ebola virus disease. [PDF]
Turcinovic J +14 more
europepmc +1 more source
Mapping the global evidence base of bundibugyo ebolavirus disease: a systematic scoping review of research gaps and preparedness priorities. [PDF]
Boatemaa A, Osei B, Forkuo GO.
europepmc +1 more source
Engineered bispecific antibodies achieve broad and potent protection against multiple ebolavirus species. [PDF]
Zhou J +15 more
europepmc +1 more source
Temporal transcriptomics identifies early-response and infection-condition-specific modules guiding host-directed anti-EBOV therapeutics. [PDF]
Zhang N +9 more
europepmc +1 more source
Whole-Genome Sequencing for High-Consequence Emerging RNA Viruses: Strategy Selection for Bundibugyo Virus Disease Under 2026 Outbreak Constraints. [PDF]
Kopp K.
europepmc +1 more source
Viral RNA persistence and long-term consequences following acute infection with Risk Group 4 zoonotic viruses. [PDF]
Li H, Pickering BS.
europepmc +1 more source
Cross-reactive Bundibugyo antibody responses after licensed Ebola vaccines
Lhomme E +17 more
europepmc +1 more source
Lactating Mothers Infected With Ebola Virus: EBOV RT-PCR of Blood Only May Be Insufficient [PDF]
We describe two Ebola virus (EBOV) RT-PCR discordant mother–child pairs. In the first, blood from the breastfeeding mother, recovering from EBOV infection, tested negative twice but her urine tested positive.
Tom Decroo, Sophie Gryseels, M Moreau
exaly +2 more sources

